Coats plus is a highly pleiotropic disorder particularly affecting the eye, brain, bone and gastrointestinal tract. Here, we show that Coats plus results from mutations in CTC1, encoding conserved telomere maintenance component 1, a member of the mammalian homolog of the yeast heterotrimeric CST telomeric capping complex. Consistent with the observation of shortened telomeres in an Arabidopsis CTC1 mutant and the phenotypic overlap of Coats plus with the telomeric maintenance disorders comprising dyskeratosis congenita, we observed shortened telomeres in three individuals with Coats plus and an increase in spontaneous γH2AX-positive cells in cell lines derived from two affected individuals. CTC1 is also a subunit of the α-accessory factor (AAF) complex, stimulating the activity of DNA polymerase-α primase, the only enzyme known to initiate DNA replication in eukaryotic cells. Thus, CTC1 may have a function in DNA metabolism that is necessary for but not specific to telomeric integrity.
Access optionsAccess options
Subscribe to Journal
Get full journal access for 1 year
only $18.75 per issue
All prices are NET prices.
VAT will be added later in the checkout.
Rent or Buy article
Get time limited or full article access on ReadCube.
All prices are NET prices.
Jain, D. & Cooper, J.P. Telomeric strategies: means to an end. Annu. Rev. Genet. 44, 243–269 (2010).
Savage, S.A. & Bertuch, A.A. The genetics and clinical manifestations of telomere biology disorders. Genet. Med. 12, 753–764 (2010).
Nelson, N.D. & Bertuch, A.A. Dyskeratosis congenita as a disorder of telomere maintenance. Mutat. Res. published online, doi:10.1016/j.mrfmmm.2011.06.008 (2 July 2011).
Tolmie, J.L., Browne, B.H., McGettrick, P.M. & Stephenson, J.B. A familial syndrome with coats' reaction retinal angiomas, hair and nail defects and intracranial calcification. Eye (Lond.) 2, 297–303 (1988).
Crow, Y.J. et al. Coats' plus: a progressive familial syndrome of bilateral Coats' disease, characteristic cerebral calcification, leukoencephalopathy, slow pre- and post-natal linear growth and defects of bone marrow and integument. Neuropediatrics 35, 10–19 (2004).
Nagae-Poetscher, L.M. et al. Leukoencephalopathy, cerebral calcifications, and cysts: new observations. Neurology 62, 1206–1209 (2004).
Linnankivi, T. et al. Cerebroretinal microangiopathy with calcifications and cysts. Neurology 67, 1437–1443 (2006).
Briggs, T.A. et al. Cerebroretinal microangiopathy with calcifications and cysts (CRMCC). Am. J. Med. Genet. A. 146A, 182–190 (2008).
Briggs, T.A. et al. Treatment of gastrointestinal bleeding in a probable case of cerebroretinal microangiopathy with calcifications and cysts. Mol. Syndromol. 1, 159–162 (2011).
Labrune, P. et al. Extensive brain calcifications, leukodystrophy, and formation of parenchymal cysts: a new progressive disorder due to diffuse cerebral microangiopathy. Neurology 46, 1297–1301 (1996).
Linger, B.R. & Price, C.M. Conservation of telomere protein complexes: shuffling through evolution. Crit. Rev. Biochem. Mol. Biol. 44, 434–446 (2009).
Price, C.M. et al. Evolution of CST function in telomere maintenance. Cell Cycle 9, 3157–3165 (2010).
Surovtseva, Y.V. et al. Conserved telomere maintenance component 1 interacts with STN1 and maintains chromosome ends in higher eukaryotes. Mol. Cell 36, 207–218 (2009).
Miyake, Y. et al. RPA-like mammalian Ctc1-Stn1-Ten1 complex binds to single-stranded DNA and protects telomeres independently of the Pot1 pathway. Mol. Cell 36, 193–206 (2009).
Baerlocher, G.M., Vulto, I., de Jong, G. & Lansdorp, P.M. Flow cytometry and FISH to measure the average length of telomeres (flow FISH). Nat. Protoc. 1, 2365–2376 (2006).
Casteel, D.E. et al. A DNA polymerase-α·primase cofactor with homology to replication protein A-32 regulates DNA replication in mammalian cells. J. Biol. Chem. 284, 5807–5818 (2009).
Goulian, M. & Heard, C.J. The mechanism of action of an accessory protein for DNA polymerase α/primase. J. Biol. Chem. 265, 13231–13239 (1990).
Giraud-Panis, M.J., Teixeira, M.T., Geli, V. & Gilson, E. CST meets shelterin to keep telomeres in check. Mol. Cell 39, 665–676 (2010).
We are very grateful to the affected families for their involvement in our research. Y.J.C. acknowledges the Manchester National Institute for Health Research (NIHR) Biomedical Research Centre. This work has received support from the Great Ormond Street Hospital Children's Charity and from the Newlife Foundation. We thank the NHLBI Grand Opportunity (GO) Exome Sequencing Project and acknowledge its ongoing studies that produced and provided exome variant calls for comparison, including the Lung GO Sequencing Project (HL-102923), the Women's Health Initiative (WHI) Sequencing Project (HL-102924), the Broad GO Sequencing Project (HL-102925), the Seattle GO Sequencing Project (HL-102926) and the Heart GO Sequencing Project (HL-103010). We also thank G. Forte for organizing courier delivery of patient materials.
The authors declare no competing financial interests.
About this article
Nucleic Acids Research (2019)
British Journal of Haematology (2019)
Life Science Alliance (2019)
Aplastic Anemia & MDS International Foundation (AA&MDSIF): Bone Marrow Failure Disease Scientific Symposium 2018
Leukemia Research (2019)
Revue Neurologique (2019)